- Free worldwide shipping, tracked and insured
- Same day dispatch, customs handled
- Certificate of analysis for every batch
- Stimulates collagen synthesis in studies
- Wound healing and tissue remodeling
- Antioxidant properties
Reference data
GHK-Cu (Copper Peptide) specifications
- Purity
- 99.8%
- CAS number
- 89030-95-5
- PubChem CID
- 378611
Quality
Independently verified, batch by batch
Tested every batch
Every batch of GHK-Cu (Copper Peptide) is independently analyzed by a third-party laboratory before it is released.
Independently verified
Identity and purity are confirmed by an independent third-party laboratory. This batch is verified to 99.8% purity.
Certificate of analysis
Every batch is independently tested with a certificate of analysis. We send a digital COA with your order.
Reviews
What researchers say about GHK-Cu (Copper Peptide)
Fast turnaround
Ordered GHK-Cu monday, had it by thursday. Packaging was good. Ran copper content assay and its within spec. Will reorder when we need more
Works
NAD+ dissolved cleanly, worked well in our sirtuin activation assays. Paperwork and COA were all there. Will order again when we run out
GHK-Cu came through
Running GHK-Cu in our wound healing models. Copper content matched the COA and the peptide is performing as expected. Ordered Tuesday got it Friday in Hyderabad. No complaints
GHK-Cu is fine
Copper peptide came in about a week to Vancouver. Quality seems good, ran copper content and its within range. Took a couple days to get a response from support when I had a question about reconstitution though
GHK-Cu (Copper Peptide) FAQ
Shipping GHK-Cu (Copper Peptide) to India?
Free shipping, UPI payments, INR pricing, and same-day dispatch.
Related Products
NAD+
99.00% pureNicotinamide adenine dinucleotide coenzyme for cellular energy metabolism, DNA repair, and longevity research.
MT-2 (Melanotan 2)
99.10% pureHigh-purity (99.10%) MT-2 Melanotan 2 research peptide. Synthetic melanocortin agonist for pigmentation pathways, photoprotection, and MC receptor studies.
